Cargando…
Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Glaucoma is a neurodegenerative disease that features progressive loss of retinal ganglion cells (RGCs). Increasing evidences have revealed that impaired mitochondrial dynamics occurs early in neurodegenerative diseases. Optic Atrophy Type 1 (OPA1), a mitochondrial fusion protein, has recently been...
Autores principales: | Hu, Xinxin, Dai, Yi, Zhang, Rong, Shang, Kunte, Sun, Xinghuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172338/ https://www.ncbi.nlm.nih.gov/pubmed/30323741 http://dx.doi.org/10.3389/fnmol.2018.00350 |
Ejemplares similares
-
Overexpression of parkin protects retinal ganglion cells in experimental glaucoma
por: Dai, Yi, et al.
Publicado: (2018) -
Parkin overexpression protects retinal ganglion cells against glutamate excitotoxicity
por: Hu, Xinxin, et al.
Publicado: (2017) -
Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma‐induced optic atrophy
por: Chen, Qianbo, et al.
Publicado: (2019) -
Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma
por: Ju, Won-Kyu, et al.
Publicado: (2010) -
Fucoxanthin protects retinal ganglion cells and promotes parkin-mediated mitophagy against glutamate excitotoxicity
por: Lian, Wei, et al.
Publicado: (2023)